Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
$2.39
-1.2%
$1.89
$1.21
$3.08
$90.49M-0.21101,844 shs56,114 shs
HOOKIPA Pharma Inc. stock logo
HOOK
HOOKIPA Pharma
$0.91
-1.9%
$0.90
$0.72
$4.40
$11.09M0.97110,048 shs2,746 shs
IRIDEX Corporation stock logo
IRIX
IRIDEX
$1.15
$1.29
$0.78
$1.95
$19.54M0.6381,143 shs22,383 shs
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
$3.16
-1.4%
$7.36
$1.87
$303.25
$8.49M1.163.32 million shs13.69 million shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
0.00%-3.60%+7.74%+47.58%-13.35%
HOOKIPA Pharma Inc. stock logo
HOOK
HOOKIPA Pharma
0.00%-4.21%-2.74%-29.47%-79.13%
IRIDEX Corporation stock logo
IRIX
IRIDEX
0.00%-3.36%-14.18%+30.40%-35.75%
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
0.00%0.00%0.00%-67.67%-99.44%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
$2.39
-1.2%
$1.89
$1.21
$3.08
$90.49M-0.21101,844 shs56,114 shs
HOOKIPA Pharma Inc. stock logo
HOOK
HOOKIPA Pharma
$0.91
-1.9%
$0.90
$0.72
$4.40
$11.09M0.97110,048 shs2,746 shs
IRIDEX Corporation stock logo
IRIX
IRIDEX
$1.15
$1.29
$0.78
$1.95
$19.54M0.6381,143 shs22,383 shs
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
$3.16
-1.4%
$7.36
$1.87
$303.25
$8.49M1.163.32 million shs13.69 million shs
7 Stocks to Ride The A.I. Megaboom Cover


We are about to experience the greatest A.I. boom in stock market history...

Thanks to a pivotal economic catalyst, specific tech stocks will skyrocket just like they did during the "dot com" boom in the 1990s.

That’s why, we’ve hand-selected 7 tiny tech disruptor stocks positioned to surge.

  1. The first pick is a tiny under-the-radar A.I. stock that's trading for just $3.00. This company already has 98 registered patents for cutting-edge voice and sound recognition technology... And has lined up major partnerships with some of the biggest names in the auto, tech, and music industry... plus many more.
  2. The second pick presents an affordable avenue to bolster EVs and AI development…. Analysts are calling this stock a “buy” right now and predict a high price target of $19.20, substantially more than its current $6 trading price.
  3. Our final and favorite pick is generating a brand-new kind of AI. It's believed this tech will be bigger than the current well-known leader in this industry… Analysts predict this innovative tech is gearing up to create a tidal wave of new wealth, fueling a $15.7 TRILLION market boom.

Right now, we’re staring down the barrel of a true once-in-a-lifetime moment. As an investment opportunity, this kind of breakthrough doesn't come along every day.

And the window to get in on the ground-floor — maximizing profit potential from this expected market surge — is closing quickly...

Simply enter your email below to get the names and tickers of the 7 small stocks with potential to make investors very, very happy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
0.00%-3.60%+7.74%+47.58%-13.35%
HOOKIPA Pharma Inc. stock logo
HOOK
HOOKIPA Pharma
0.00%-4.21%-2.74%-29.47%-79.13%
IRIDEX Corporation stock logo
IRIX
IRIDEX
0.00%-3.36%-14.18%+30.40%-35.75%
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
0.00%0.00%0.00%-67.67%-99.44%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
2.33
Hold$8.50255.65% Upside
HOOKIPA Pharma Inc. stock logo
HOOK
HOOKIPA Pharma
2.33
Hold$4.50394.51% Upside
IRIDEX Corporation stock logo
IRIX
IRIDEX
0.00
N/AN/AN/A
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
0.00
N/AN/AN/A

Current Analyst Ratings Breakdown

CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
$69.18M1.29N/AN/A$1.18 per share2.03
HOOKIPA Pharma Inc. stock logo
HOOK
HOOKIPA Pharma
$9.35M1.19N/AN/A$4.25 per share0.21
IRIDEX Corporation stock logo
IRIX
IRIDEX
$48.67M0.40N/AN/A$0.13 per share8.85
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
$8.01M1.06N/AN/A($8.66) per share-0.36
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
-$20.58M-$0.610.00N/AN/A-33.49%-56.85%-26.83%11/6/2025 (Estimated)
HOOKIPA Pharma Inc. stock logo
HOOK
HOOKIPA Pharma
-$43.50M-$5.85N/AN/AN/A-785.66%-120.09%-77.14%11/12/2025 (Estimated)
IRIDEX Corporation stock logo
IRIX
IRIDEX
-$8.91M-$0.330.00N/A-10.95%-386.93%-17.42%11/11/2025 (Estimated)
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
-$7.13M-$108.27N/AN/A-69.71%-547.65%-79.89%11/13/2025 (Estimated)

Latest RSLS, EDAP, HOOK, and IRIX Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/14/2025Q2 2025
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
N/A-$9.00N/A-$2.25N/A$1.24 million
8/12/2025Q2 2025
IRIDEX Corporation stock logo
IRIX
IRIDEX
-$0.09-$0.06+$0.03-$0.06$13.10 million$13.57 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
N/AN/AN/AN/AN/A
HOOKIPA Pharma Inc. stock logo
HOOK
HOOKIPA Pharma
N/AN/AN/AN/AN/A
IRIDEX Corporation stock logo
IRIX
IRIDEX
N/AN/AN/AN/AN/A
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
0.04
1.51
1.05
HOOKIPA Pharma Inc. stock logo
HOOK
HOOKIPA Pharma
N/A
3.61
3.61
IRIDEX Corporation stock logo
IRIX
IRIDEX
62.29
1.96
1.34
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
N/A
1.53
0.91

Institutional Ownership

CompanyInstitutional Ownership
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
62.74%
HOOKIPA Pharma Inc. stock logo
HOOK
HOOKIPA Pharma
63.88%
IRIDEX Corporation stock logo
IRIX
IRIDEX
20.10%
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
22.06%

Insider Ownership

CompanyInsider Ownership
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
0.23%
HOOKIPA Pharma Inc. stock logo
HOOK
HOOKIPA Pharma
3.30%
IRIDEX Corporation stock logo
IRIX
IRIDEX
7.40%
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
0.01%
CompanyEmployeesShares OutstandingFree FloatOptionable
EDAP TMS S.A. stock logo
EDAP
EDAP TMS
23037.39 million37.31 millionOptionable
HOOKIPA Pharma Inc. stock logo
HOOK
HOOKIPA Pharma
16012.19 million11.79 millionOptionable
IRIDEX Corporation stock logo
IRIX
IRIDEX
12016.99 million15.74 millionOptionable
ReShape Lifesciences Inc. stock logo
RSLS
ReShape Lifesciences
502.69 million2.39 millionNot Optionable

Recent News About These Companies

3 Penny Stocks to Watch Now, 8/14/25

New MarketBeat Followers Over Time

Media Sentiment Over Time

EDAP TMS stock logo

EDAP TMS NASDAQ:EDAP

$2.39 -0.03 (-1.24%)
Closing price 03:53 PM Eastern
Extended Trading
$2.38 -0.01 (-0.46%)
As of 05:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

EDAP TMS SA is a holding company, which, through its subsidiary, engages in the development, production, and marketing of minimally invasive medical devices for urological diseases. It operates through the High Intensity Focused Ultrasound (HIFU) and Urology Devices and Services (UDS) segments. The HIFU segment develops, manufactures, and markets devices for the minimally invasive ablation of certain types of localized tumors using HIFU technology. The UDS segment focuses on the development, marketing, manufacturing, and servicing of medical devices for the minimally invasive diagnosis or treatment of urological disorders, mainly urinary stones, and other clinical indications. The company was founded on December 3, 1979 and is headquartered in Vaulx-en-Velin, France.

HOOKIPA Pharma stock logo

HOOKIPA Pharma NASDAQ:HOOK

$0.91 -0.02 (-1.94%)
As of 01:33 PM Eastern

HOOKIPA Pharma Inc., a clinical-stage biopharmaceutical company, develops immunotherapeutics targeting infectious diseases and cancers based on its proprietary arenavirus platform. The company's lead infectious disease product candidate is HB-101, which is in a randomized double-blinded Phase 2 clinical trial in cytomegalovirus-negative patients awaiting kidney transplantation from cytomegalovirus-positive donors. Its lead oncology product candidates are HB-201 and HB-202 that are in preclinical studies for the treatment of human papillomavirus-positive cancers. The company has a collaboration with Gilead Sciences, Inc. to develop arenavirus based therapeutics to treat hepatitis B virus and human immunodeficiency virus infections. HOOKIPA Pharma Inc. was founded in 2011 and is headquartered in New York, New York.

IRIDEX stock logo

IRIDEX NASDAQ:IRIX

$1.15 0.00 (0.00%)
Closing price 04:00 PM Eastern
Extended Trading
$1.16 +0.01 (+0.87%)
As of 04:11 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in ophthalmology. It offers laser consoles, such as Cyclo G6 laser system for use in the treatment of glaucoma; IQ 532 and IQ 577 laser systems, which are used for the treatment of retinal disorders; and OcuLight TX, OcuLight SL, OcuLight SLx, OcuLight GL, and OcuLight GLx laser photocoagulation systems that are used to treat proliferative diabetic retinopathy, macular holes, retinal tears, and detachments. The company also provides delivery devices, including TxCell scanning laser delivery system that allows the physician to perform multi-spot pattern scanning; slit lamp adapter, which allows the physician to utilize a standard slit lamp in diagnosis and treatment procedures; and laser indirect ophthalmoscope for use in procedures to treat peripheral retinal disorders. It offers MicroPulse P3 Probe, which is used with its Cylco G6 laser system to perform MicroPulse transscleral laser therapy; G-Probe, which is used in procedures to treat uncontrolled glaucoma; G-Probe and G-Probe Illuminate, which are used in procedures to treat refractory glaucoma; and EndoProbe family of products for use in vitrectomy procedures. The company serves ophthalmologists, research and teaching hospitals, government installations, surgical centers, hospitals, veterinary practices, and office clinics. It markets its products through direct and independent sales force in the United States, as well as through independent distributors internationally. The company was formerly known as IRIS Medical Instruments, Inc. and changed its name to IRIDEX Corporation in November 1995. IRIDEX Corporation was incorporated in 1989 and is headquartered in Mountain View, California.

ReShape Lifesciences stock logo

ReShape Lifesciences NASDAQ:RSLS

ReShape Lifesciences Inc. provides products and services that manages and treat obesity and metabolic diseases in the United States, Australia, Europe, and internationally. The company's product portfolio includes Lap-Band System, a minimally invasive long-term treatment of severe obesity and more invasive surgical stapling procedures, such as the gastric bypass or sleeve gastrectomy; Lap-Band 2.0 System, an adjustable postoperatively to increase or decrease the pressure to the band in order to optimize an individual's comfort and therapy effectiveness; and ReShape Calibration Tubes, that fits the lesser curvature of the stomach to reach the pylorus. It is also involved in developing ReShape Obalon Balloon System, consists of a swallowable capsule that tracks and displays the location of the balloon during placement; and ReShape Diabetes Bloc-Stim Neuromodulation (DBSN) device, a technology that is in development for the treatment of type 2 diabetes mellitus. The company was formerly known as EnteroMedics Inc. and changed its name to ReShape Lifesciences Inc. in 2017. ReShape Lifesciences Inc. was incorporated in 2002 and is headquartered in Irvine, California.